Colorectal Cancer Clinical Trial
Official title:
Do Patients With Colorectal Cancer Understand That Their Family is at Increased Risk?
The purpose of this study is to assess whether patients with colorectal cancer understand
that their first-degree relatives are at increased risk of getting the cancer themselves and
therefore should be screened early. Among patients who do understand the risks to their
family, we plan to determine who they identify as the source of their information and
whether they have acted upon this information and advised family members to be screened. We
hypothesize that many patients with colorectal cancer do not have a correct understanding of
the risks to their first-degree relatives and the recommendations that they be screened
early.
If this hypothesis is shown to be true, it can be used to direct improved and more diligent
patient education. This, in turn, will hopefully increase the low screening rates among
first-degree relatives, and, thereby, save lives in this high-risk population.
1. The primary physician of patients with colorectal cancer will be contacted and asked
permission to contact their patient to discuss his or her understanding of familial
risk before patient is contacted.
2. A letter will be sent to all patients prior to being contacted, notifying them that all
identifying information will be kept confidential and they may decline to participate
at any time.
3. Patients will be called and asked a series of questions about their understanding of
familial risk of colon cancer, the need for early screening and where they learned what
they know. If the patient has lacking knowledge they will be educated.
4. Each patient will be sent informational brochures about colon cancer after the phone
survey.
5. Six months later, the patients will be contacted again and asked a series of questions
about their understanding of familial risk of colon cancer and the need for early
screening to access how much impact the informational brochures had on their knowledge
of cancer risk. Patients will be asked one additional demographic question about the
highest level of education that they have completed.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT00098787 -
Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer
|
Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05425940 -
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
|
Phase 3 | |
Suspended |
NCT04595604 -
Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery.
|
N/A | |
Completed |
NCT03414125 -
Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening
|
N/A | |
Completed |
NCT02963831 -
A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies
|
Phase 1/Phase 2 | |
Recruiting |
NCT05489211 -
Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
|
Phase 2 | |
Terminated |
NCT01847599 -
Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib
|
N/A | |
Completed |
NCT05799976 -
Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure
|
N/A | |
Recruiting |
NCT03874026 -
Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03170960 -
Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT03181334 -
The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation
|
N/A | |
Completed |
NCT03167125 -
Participatory Research to Advance Colon Cancer Prevention
|
N/A | |
Recruiting |
NCT04258137 -
Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study
|
N/A | |
Recruiting |
NCT05568420 -
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
|
||
Recruiting |
NCT02972541 -
Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer
|
N/A | |
Completed |
NCT02876224 -
Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors
|
Phase 1 | |
Completed |
NCT01943500 -
Collection of Blood Specimens for Circulating Tumor Cell Analysis
|
N/A |